| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |